about
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyEmergence of Klebsiella pneumoniae carbapenemase-producing bacteriaMethodology in improving antibiotic implementation policiesEscherichia coli β-Lactamases: What Really MattersLaboratory Detection and Clinical Implication of Oxacillinase-48 like Carbapenemase: The Hidden ThreatCan we prevent antimicrobial resistance by using antimicrobials better?Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin ResistanceDuration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection-- 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trialsHigh-Resolution Crystal Structure of the Subclass B3 Metallo- -Lactamase BJP-1: Rational Basis for Substrate Specificity and Interaction with SulfonamidesA structural view of the antibiotic degradation enzyme NDM-1 from a superbugStructures of the Class D Carbapenemase OXA-24 from Acinetobacter baumannii in Complex with DoripenemCrystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroateMutagenesis of Zinc Ligand Residue Cys221 Reveals Plasticity in the IMP-1 Metallo- -Lactamase Active SiteEvolution to carbapenem-hydrolyzing activity in noncarbapenemase class D -lactamase OXA-10 by rational protein designStructural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by HalogensMolecular characterization of multidrug resistant hospital isolates using the antimicrobial resistance determinant microarrayVirtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbADiverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in KunmingEvolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?Exploring the Diversity and Antimicrobial Potential of Marine Actinobacteria from the Comau Fjord in Northern Patagonia, ChileEnhanced antimicrobial activity of engineered human lysozymeExploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health.NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanismConjugative plasmids of Neisseria gonorrhoeae.Tetracycline-resistant coliforms in the effluent of the main sewage treatment plant in Hamilton, Ontario - do they have a common ancestral strain?"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China.Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?Quinolone resistance in Escherichia coli from Accra, Ghana.Sequencing and characterization of Pseudomonas aeruginosa phage JG004.Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membraneAntibiotics and bacterial resistance in the 21st century.The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa.Plant essential oils and their constituents in coping with multidrug-resistant bacteria.Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria.Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections.Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers
P2860
Q24617818-12C7F3C2-4404-42D4-A016-8A8021630CBCQ24618178-611CC196-01EB-4101-A5A7-CE461CDB299AQ26744801-0D9B54C2-6CF3-4F52-99C5-28A0323F6F30Q26749590-0262416A-ADB7-4BA5-BB51-8F7E7C6935D3Q26751295-37F3E5A2-B019-4BB8-8DBF-2FD475898436Q26829707-23C95C8B-E3FB-43D7-8CFB-DE6CCAE33D67Q26853135-BFE19F6B-1AE5-4B32-ACDB-EC318EF53EBDQ27003126-0F20F89E-37B9-4847-99C6-48E54BC2C382Q27664009-93B27678-2C29-49A9-9221-BC78149CCC4CQ27666241-35E484FD-8FDA-4A89-BAE7-791778F54244Q27666516-B7DD253F-72C5-4D0A-BB9D-1C2AB516DDECQ27667765-33AF4735-3C36-4FA5-A45E-B770D72842AEQ27671609-1E923F86-109E-4FEB-A809-60E5E1AB98C4Q27675331-1AE4F142-B62A-4E41-9751-0155E385DC71Q27700611-6A4E274B-D532-42BE-A605-B9469FC57753Q28534905-196DF7CB-D566-4923-BBC2-2EFBF3A453E0Q28546904-210A1B1A-0CF8-4617-9C2C-1F54E659D784Q28602456-E4C3BDF9-10BB-4B7E-89FD-A92CF23434EDQ28752557-D005E2FB-655C-4FB6-ABB0-6F435FD3BF38Q28829854-1F1BD17F-2139-40E9-87D6-32DE5BC71552Q30496665-FF88A707-7B23-48EA-B62F-774C7B8BB4BBQ30498731-099578DB-C458-43F2-814B-4B3C19D102D6Q30539117-65E35B1D-7292-45E0-87F2-9B75ECF48C0DQ33550814-6C5468D6-CEAC-437E-9400-5186001E94EDQ33638316-9AC3B059-E902-4A70-AD4D-231353E802EBQ33648238-1B1C831A-B168-4822-B86F-03FC5352E826Q33715837-0D8593E2-1B1D-4874-B1FE-C59D77991DE1Q33803459-0298E216-9F19-4383-A05A-F00EFF03761CQ33830227-A476B331-7F74-4726-AA01-6A37AEE94EE2Q33899228-B4618016-9A78-4F1B-9EE2-F7FE68DD5063Q33997664-CCD42608-4977-44CA-AEED-F8B829D43EDCQ34027016-B4BB71EC-162E-45A5-8E67-B14366EB252FQ34045186-C9A9CCB9-D6CA-4B77-969D-DF0557885BF7Q34156349-3CE2E962-4DEA-4F2F-97CB-AD70EEEDD135Q34167642-748E830C-A488-4A0E-B8F0-DB1D3BD38550Q34297269-053CB9C3-EC4C-4F1D-AAFA-3A6D39888669Q34325328-754AB540-0EDC-4252-AB25-D758B253EBCDQ34325573-F8A2A2DF-F21B-4A6C-9112-A08BF2FE4138Q34402134-E6BA145E-0868-40D4-A11D-6B057C4A6C85Q34417003-45B3B1B8-A731-49E7-A19A-6DEB1214EA4C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Has the era of untreatable infections arrived?
@en
Has the era of untreatable infections arrived?
@nl
type
label
Has the era of untreatable infections arrived?
@en
Has the era of untreatable infections arrived?
@nl
prefLabel
Has the era of untreatable infections arrived?
@en
Has the era of untreatable infections arrived?
@nl
P356
P1476
Has the era of untreatable infections arrived?
@en
P2093
David M Livermore
P304
P356
10.1093/JAC/DKP255
P407
P478
64 Suppl 1
P577
2009-09-01T00:00:00Z